UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 585

Sortiert nach

The diagnosis and management of NK/T-cell lymphomas

Journal of hematology and oncology, 2017-04, Vol.10 (1), p.85-85, Article 85

2017

Link zum Volltext

Verfügbarkeit prüfen

EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment

Frontiers in oncology, 2019-02, Vol.9, p.62-62

2019

Link zum Volltext

Verfügbarkeit prüfen

Oral arsenic trioxide, all‐trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long‐term results and unique prognostic indicators

Cancer, 2020-07, Vol.126 (14), p.3244-3254

2020

Link zum Volltext

Verfügbarkeit prüfen

Arsenic trioxide inhibits anaplastic lymphoma kinase (ALK)‐positive diffuse large B‐cell lymphoma through targeting ALK‐fusion oncoprotein

British journal of haematology, 2021-09, Vol.194 (6), p.1085-1090

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

Journal of clinical oncology, 2011-11, Vol.29 (33), p.4410-4416

2011

Link zum Volltext

Verfügbarkeit prüfen

How we treat NK/T-cell lymphomas

Journal of hematology and oncology, 2022-06, Vol.15 (1), p.74-74, Article 74

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of dexamethasone, methotrexate, ifosfamide, l‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natural killer (NK)/T‐cell lymphoma and leukemia

Cancer science, 2008-05, Vol.99 (5), p.1016-1020

2008

Link zum Volltext

Verfügbarkeit prüfen

PD1 blockade with low-dose nivolumab in NK/T cell lymphoma failing l-asparaginase: efficacy and safety

Annals of hematology, 2018, Vol.97 (1), p.193-196

2018

Link zum Volltext

Verfügbarkeit prüfen

CD3+CD4+ lymphoid neoplasm: diagnostic clues for plasmablastic lymphoma instead of peripheral T-cell lymphoma

Annals of hematology, 2022, Vol.101 (1), p.223-226

2022

Link zum Volltext

Verfügbarkeit prüfen

STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia

Cancer science, 2014-03, Vol.105 (3), p.342-346

2014

Link zum Volltext

Verfügbarkeit prüfen

CD3+/CD56+ EBV+ neoplasms in the nose and upper aerodigestive tract: potential misdiagnosis of plasma cell malignancies as NK/T cell lymphoma

Annals of hematology, 2021-04, Vol.100 (4), p.1101-1104

2021

Link zum Volltext

Verfügbarkeit prüfen

The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia

British journal of haematology, 2017-03, Vol.176 (6), p.991-994

2017

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies

Cancers, 2022-01, Vol.14 (3), p.597

2022

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II

Frontiers in oncology, 2023-06, Vol.13, p.1238486-1238486

2023

Link zum Volltext

Verfügbarkeit prüfen

Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study

Cancer, 2018-06, Vol.124 (11), p.2316-2326

2018

Link zum Volltext

Verfügbarkeit prüfen

Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target

Experimental & molecular medicine, 2015-01, Vol.47 (1), p.e136-e136

2015

Link zum Volltext

Verfügbarkeit prüfen

How I treat NK/T-cell lymphomas

Blood, 2013-06, Vol.121 (25), p.4997-5005

2013

Link zum Volltext

Verfügbarkeit prüfen

Epstein-Barr virus–positive diffuse large B-cell lymphoma after frontline brentuximab vedotin treatment of classical Hodgkin lymphoma

Annals of hematology, 2022-05, Vol.101 (5), p.1149-1152

2022

Link zum Volltext

Verfügbarkeit prüfen

Low‐dose pembrolizumab induced remission in patients with refractory classical Hodgkin lymphoma

British journal of haematology, 2017-01, Vol.176 (1), p.131-132

2017

Link zum Volltext

Verfügbarkeit prüfen

Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond

Frontiers in oncology, 2022-11, Vol.12, p.1026478-1026478

2022

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study

Hepatology (Baltimore, Md.), 2017-05, Vol.65 (5), p.1451-1461

2017

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Acute Promyelocytic Leukemia - Towards A Chemotherapy-Free Approach to Cure in All Patients

Frontiers in oncology, 2022-01, Vol.11, p.831308-831308

2022

Link zum Volltext

Verfügbarkeit prüfen

Kinetics and Risk of De Novo Hepatitis B Infection in HBsAg–Negative Patients Undergoing Cytotoxic Chemotherapy

Gastroenterology (New York, N.Y. 1943), 2006-07, Vol.131 (1), p.59-68

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 585

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(455)
Mit Volltextzugriff
(557)

Publikationsform

Artikel
(479)
Buchkapitel
(53)
Berichte
(52)
Bücher
(1)

Sprache

Englisch
(582)
Japanisch
(48)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(337)
Life Sciences & Biomedicine
(335)
Humans
(315)
Male
(195)
Hematology
(190)
Female
(181)
Oncology
(171)
Middle Aged
(162)
Adult
(143)
Aged
(111)
Biological And Medical Sciences
(90)
Medical Sciences
(89)
Medicine
(81)
Medicine & Public Health
(79)
Hematologic And Hematopoietic Diseases
(56)
Letter To The Editor
(54)
Treatment Outcome
(54)
Aged, 80 And Over
(53)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(47)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(43)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The diagnosis and management of NK/T-cell lymphomas

EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment

Oral arsenic trioxide, all‐trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long‐term results and unique prognostic indicators

Arsenic trioxide inhibits anaplastic lymphoma kinase (ALK)‐positive diffuse large B‐cell lymphoma through targeting ALK‐fusion oncoprotein

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

How we treat NK/T-cell lymphomas

Phase I study of dexamethasone, methotrexate, ifosfamide, l‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natural killer (NK)/T‐cell lymphoma and leukemia

PD1 blockade with low-dose nivolumab in NK/T cell lymphoma failing l-asparaginase: efficacy and safety

CD3+CD4+ lymphoid neoplasm: diagnostic clues for plasmablastic lymphoma instead of peripheral T-cell lymphoma

STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia

CD3+/CD56+ EBV+ neoplasms in the nose and upper aerodigestive tract: potential misdiagnosis of plasma cell malignancies as NK/T cell lymphoma

The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia

Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies

Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II

Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study

Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target

How I treat NK/T-cell lymphomas

Epstein-Barr virus–positive diffuse large B-cell lymphoma after frontline brentuximab vedotin treatment of classical Hodgkin lymphoma

Low‐dose pembrolizumab induced remission in patients with refractory classical Hodgkin lymphoma

Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms‐like tyrosine kinase 3

Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond

Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study

Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study

Editorial: Acute Promyelocytic Leukemia - Towards A Chemotherapy-Free Approach to Cure in All Patients

Kinetics and Risk of De Novo Hepatitis B Infection in HBsAg–Negative Patients Undergoing Cytotoxic Chemotherapy

Suchergebnisse filtern